NeoGenomics, Inc.NeoGenomics, Inc.NeoGenomics, Inc.

NeoGenomics, Inc.

No trades
See on Supercharts

Price target

20.500.00 0.00%
The 10 analysts offering 1 year price forecasts for NEO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 13 analysts giving stock ratings to NEO in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

NEO EPS for the last quarter is −0.02 USD despite the estimation of −0.04 USD. In the next quarter EPS is expected to reach −0.00 USD. Track more of NeoGenomics, Inc. financials and stay on top of what is up with the company.
In the next quarter NeoGenomics, Inc. revenue is expected to reach ‪162.36 M‬ USD. Check out NeoGenomics, Inc. revenue and earnings and make informed decisions.
According to analysts, NEO price target is 20.50 USD with a max estimate of 28.00 USD and a min estimate of 17.00 USD. Check if this forecast comes true in a year, meanwhile watch NeoGenomics, Inc. stock price chart and keep track of the current situation with NEO news and stock market news.
We've gathered opinions of 13 analysts rating NEO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.